{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T19:44:51Z","timestamp":1774381491915,"version":"3.50.1"},"reference-count":23,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1832,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1525-1470.2010.01285.x","type":"journal-article","created":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T06:49:36Z","timestamp":1283150976000},"page":"470-475","source":"Crossref","is-referenced-by-count":29,"title":["The Self-Administered Eczema Area and Severity Index in Children with Moderate to Severe Atopic Dermatitis: Better Estimation of AD Body Surface Area Than Severity"],"prefix":"10.1111","volume":"27","author":[{"given":"Sara G.A.","family":"Van Velsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge M.","family":"Haeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla A.F.M.","family":"Bruijnzeel-Koomen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanne G.M.A.","family":"Pasmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,26]]},"reference":[{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2133.1996.tb03822.x","article-title":"Measurement of disease activity and outcome in atopic dermatitis","volume":"135","author":"Finlay","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1001\/archderm.136.6.763","article-title":"Outcome measures of disease severity in atopic eczema","volume":"136","author":"Charman","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1046\/j.1365-2133.2002.05031.x","article-title":"Use of the self-administered eczema area and severity index by parent caregivers: results of a validation study","volume":"147","author":"Housman","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.jaci.2007.08.011","article-title":"What are the best outcome measurements for atopic eczema? A systematic review","volume":"120","author":"Schmitt","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis","volume":"10","author":"Hanifin","year":"2001","journal-title":"EASI Evaluator Group. Exp Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0301-0546(08)72551-5","article-title":"Severity scoring of atopic dermatitis: a comparison of two scoring systems","volume":"36","author":"Rullo","year":"2008","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2007.08112.x","article-title":"Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score","volume":"157","author":"Oranje","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl 48","key":"10.1111\/j.1525-1470.2010.01285.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2133.1996.tb00706.x","article-title":"Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis","volume":"135","author":"Berth-Jones","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2133.1997.tb08750.x","article-title":"Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis","volume":"136","author":"Berth-Jones","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0190-9622(96)90281-9","article-title":"Cyclosporine in severe childhood atopic dermatitis: a multicenter study","volume":"34","author":"Berth-Jones","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1523-1747.2003.12251.x","article-title":"Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring?","volume":"120","author":"Charman","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1525-1470.2008.00783.x","article-title":"New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement","volume":"25","author":"Msika","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1046\/j.1365-2133.2002.04938.x","article-title":"Comparison of different activity parameters in atopic dermatitis: correlation with clinical scores","volume":"147","author":"Gutgesell","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-2133.2006.07201.x","article-title":"Significance of interleukin-16, macrophage-derived chemokine, eosinophil cationic protein and soluble E-selectin in reflecting disease activity of atopic dermatitis--from laboratory parameters to clinical scores","volume":"154","author":"Angelova-Fischer","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaci.2003.12.007","article-title":"Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis","volume":"113","author":"Hijnen","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1399-3038.2009.00851.x","article-title":"Serum measurement of thymus and activation-regulated chemokine\/CCL17 in children with atopic dermatitis: elevated normal levels in infancy and age-specific analysis in atopic dermatitis","volume":"20","author":"Fujisawa","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/0140-6736(93)90697-F","article-title":"Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis","volume":"341","author":"Berth-Jones","year":"1993","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1111\/j.1525-1470.2010.01285.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Arch Dermatol Venereol (Stockh)"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB20|cit20","volume-title":"SPSS Survival Manual","author":"Pallant","year":"2009"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB21|cit21","first-page":"23","article-title":"Consensus Report of the European Task Force on Atopic Dermatitis","volume":"186","author":"Severity scoring of atopic dermatitis: the SCORAD index","year":"1993","journal-title":"Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1001\/archderm.140.12.1513","article-title":"The patient-oriented eczema measure: development and initial validation of a new tool for measuring atopic eczema severity from the patients\u2019 perspective","volume":"140","author":"Charman","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1525-1470.2010.01285.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000193997","article-title":"Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study","volume":"218","author":"Vourc\u2019h-Jourdain","year":"2009","journal-title":"Dermatol"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2010.01285.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1525-1470.2010.01285.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T02:05:33Z","timestamp":1685757933000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2010.01285.x"}},"subtitle":["SA-EASI in Children with AD"],"short-title":[],"issued":{"date-parts":[[2010,8,26]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2010.01285.x","relation":{},"ISSN":["0736-8046"],"issn-type":[{"value":"0736-8046","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,26]]}}}